methane has been researched along with cyclin d1 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abdelrahim, M; Morrow, D; Phillips, T; Porter, W; Qin, C; Safe, S; Samudio, I; Smith, R; Spencer, K; Stewart, J | 1 |
1 other study(ies) available for methane and cyclin d1
Article | Year |
---|---|
A new class of peroxisome proliferator-activated receptor gamma (PPARgamma) agonists that inhibit growth of breast cancer cells: 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes.
Topics: 3T3-L1 Cells; Adipocytes; Animals; Apoptosis; Breast Neoplasms; Carcinogens; Cell Cycle; Cell Differentiation; Cell Division; Cell Line, Tumor; Cell Separation; Cloning, Molecular; Cyclin D1; Dose-Response Relationship, Drug; Down-Regulation; Estrogen Receptor alpha; Female; Flow Cytometry; G1 Phase; Humans; Indoles; Ligands; Luciferases; Methane; Mice; Plasmids; Prostaglandin D2; Protein Structure, Tertiary; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Receptors, Estrogen; Resting Phase, Cell Cycle; Structure-Activity Relationship; Transcription Factors; Transcriptional Activation; Transfection; Two-Hybrid System Techniques | 2004 |